Proactive Investors USA & Canada |
Stocks: Another Tuesday surge
CNNMoney After the bell, it was a tale of two biotechnology stocks. Gilead Sciences (GILD, Fortune 500) blew past earnings estimates, while Amgen (AMGN, Fortune 500) failed to live up to analysts' expectations. The biotech sector has taken a beating in recent … US STOCKS-Futures imply lower open after recent rally US STOCKS-Futures flat after six straight days of gains Why GW Pharmaceuticals, Revance Therapeutics, and Allergan Are Today's 3 … |